Merlin.net vs IM007

When choosing between Merlin.net and IM007 for remote cardiac monitoring, physicians should consider their existing device ecosystem and desired level of AI-driven data aggregation. Merlin.net, from Abbott, is specifically designed for managing data from Abbott’s own implanted cardiac devices. It offers robust features for remote follow-up, device performance monitoring, and seamless EHR integration via EHRDirect. Its strengths lie in providing a comprehensive, integrated solution for practices primarily utilizing Abbott devices, with tools like DirectAlerts for event notifications and DirectCall for patient communication.

In contrast, IM007 by Implicity offers a broader, vendor-agnostic approach, aggregating data from all major cardiac implantable electronic devices (CIEDs), including those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort. This is the key practical difference: IM007 provides a unified platform for practices managing a diverse range of devices. Its AI-driven alert management significantly reduces false positives, and it includes advanced features like the ILR ECG Analyzer and SignalHF for predicting heart failure hospitalization risk. Practices with a mixed fleet of CIEDs or those seeking advanced AI capabilities for workflow automation and predictive analytics would find IM007 more suitable.

Therefore, a physician whose practice exclusively or predominantly uses Abbott cardiac devices would likely benefit most from Merlin.net’s specialized and integrated features. Conversely, a physician managing patients with various manufacturers’ CIEDs, or one looking to leverage advanced AI for alert reduction, workflow optimization, and predictive insights across all devices, should opt for IM007.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist